FL-101 in Surgically Resectable Non-Small Cell Lung Cancer

NCT04758949 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: FL-101
DRUG: Nivolumab
DRUG: Placebo

Sponsor

Flame Biosciences